BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Business

  Cellceutix Provides Updates on IND for Cancer Drug, Initiates Collaborative Agreement With Pioneer Valley Life Sciences Institute (PVLSI) for Mitochondrial Research

  December 13, 2011

   · 

  3 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Update to TH-302 Pancreatic Data to Be Presented at the Oppenheimer Healthcare Conference

  December 13, 2011

   · 

  4 min read
• Business

  Ablynx and Merck Serono Select a Novel Nanobody Candidate, ALX-0761, for Pre-Clinical Development

  December 13, 2011

   · 

  2 min read
• Drug Development

  Ablynx Initiates Phase I Study With ALX-0171 for the Treatment of Respiratory Syncytial Virus (RSV)

  December 13, 2011

   · 

  2 min read
• Business

  Peregrine Pharmaceuticals, Inc. Reports Second Quarter 2012 Financial Results and Recent Developments

  December 13, 2011

   · 

  17 min read
• Deals

  Valeant Pharmaceuticals International Announces the Completion of the Privatization of Afexa Life Sciences Inc.

  December 13, 2011

   · 

  3 min read
• Bioniche Life Sciences Inc. E. coli Vaccine Granted Import Access to Australia

  December 13, 2011

   · 

  4 min read
• Biotech Bay

  BioCision, LLC Standardizes Histology Procedures with CoolSink™ H Line

  December 13, 2011

   · 

  2 min read
• Drug Development

  Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Phase I(a) Safety Study for CPP-115

  December 13, 2011

   · 

  1 min read
• Genetown

  FluoroPharma CEO Provides Shareholders With a “State of the Union” Communication

  December 13, 2011

   · 

  1 min read